ABOUT FRELII

Fré is an Old English word meaning “move forward” or “towards” and LII is the roman numeral for 52.

In numerology, 52 is a number of introspections and expression of a personal sense of freedom.

Frélii means to move towards a personal sense of freedom

Company Origin-

Our founder, Ian Jenkins, has dedicated his life to improving the lives of others.When his father passed away from a preventable disease it became more clear to Ian how we as a society have a lack of individual body knowledge.

Ian became inspired with an unquenchable desire to be at the forefront of evolving the medical industry towards a personalized approach to medicine. In April 2017, he became Chief Executive Officer and in January 2018, the company commenced operations, which consisted of providing personalized health and nutrition plans based on DNA sequencing and genetics provided by an extremely powerful artificial intelligence-driven computer algorithm. Since then, the company has evolved the Frelii AI-based software called “Navii” to enable significant advancements in the areas of diagnostics, healthcare, pharmacology, telehealth, insurance and even personal health and wellness.

Frelii continues to develop and grow its patented AI technology, leveraged base code and large data sets gathered from public and private partnerships. Frelii’s predictive capacity with its precision medicine and health and wellness AI has increased from 84% to 98.5%. And the flagship high-efficiency Genetic Sequencing and analysis using Frelii’s proprietary technology has increased to greater than 99% and 99.999% accuracy on whole genome and exome sequencing, respectively.

To bring this into perspective, current competitive solutions analyze about 400,000 data points, generating approximately 384 outcomes, such as diet suggestions or identification of potential health risks. The Frélii AI technology has dramatically increased the data points analyzed to more than 60 million, yielding more than 60 million outcomes. This represents a paradigm-changing jump in the availability of accurate, whole genome sequencing and analysis.

Meet Our Team

Ian Jenkins
President and CEO

Ian Jenkins read his first book on DNA when he was 6 years old and was hooked for life. He has served as the Chief Executive Officer of Frélii, Inc. (formerly known as Vican Resources, Inc.) since April 5, 2017. He has several years of experience in finance, marketing and stock analysis; however, he never strayed far from his passion in genetics, particularly in epigenetics and expression, working in labs such as Midwestern Medical University, Davidson Genetics, Nutri-Biome Research and at the helm of companies driving this segment. Prior to Frélii, Jenkins has been the Managing Partner of Unprescribed, LLC since 2016. He served as a board advisor and Director of Marketing from 2012 to 2016 at Systemic Formulas Inc., and an Industry Consultant from 2011 to 2012 in Salt Lake City, Utah. Jenkins was a Turnaround Consultant with Coleridge Group – Phoenix, Arizona, from 2010 to 2011 and Chief Executive Officer of CodeTec – Phoenix, Arizona, from 2009 to 2010. Jenkins received a Bachelor of Science in Exercise Physiology in 2007 from Utah State University and an MBA, International Business / Entrepreneurship in 2011 from the Thunderbird School of Global Management – Glendale, AZ.

Dr. Hans Jenkins
Cheif Medical Director

Jenkins was appointed to our Board of Directors in March 2018. Dr. Jenkins is highly experienced in developing lifestyle and nutrition plans for patients seeking to optimize their long-term health through preventive care. His practice prioritizes preventive health education, medical screenings, and lifestyle modifications to obtain optimal health. Dr. Jenkins graduated from Weber State University, then earned his Doctor of Osteopathy (D.O.) degree from Arizona College of Osteopathic Medicine. Following medical school, Dr. Jenkins completed a family medicine internship at John C. Lincoln Hospital in Phoenix, Arizona. An honored veteran of the United States Air Force, Dr. Jenkins served more than four years as a flight surgeon during Operation Iraqi Freedom with two deployments to combat zones. Dr. Jenkins completed his family medicine residency program at St. Joseph’s Hospital in 2011. Dr. Jenkins is the Medical Director and a primary care physician at Orn Total Health in Farmington, Utah.

Jayson Uffens
Chief Technology Officer

Jason is the Founder and CEO of a successful SAAS platform that helps connect financial institutions to meaningful engagement opportunities with customers through digital channels. Prior to this, he was the Vice President of GrubHub where he directed the creation of effective technology architecture which helped leapfrog their brand forward. He is an industry thought leader and companies from around the world seek his advice with their technology challenges.

Seth Jones
Cheif Marketing officer

Seth was appointed Chief Marketing Officer in January 2018. Mr. Jones is a marketing strategist and digital media expert. From 2011 to 2017, Mr. Jones served in various senior positions at Devinsupertramp, an extreme sports and adventure video production company, where he produced and distributed digital content that generated more than 4.5 million subscribers and over 915 million views on YouTube and over 3.2 million subscribers and over a billion views on Facebook. Mr. Jones is particularly skilled in developing marketing strategies, producing online marketing content, leveraging social media, and coordinating multi-level marketing campaigns. While at Devinsupertramp, Mr. Jones and his team were nominated for three Streamy Awards for online videos, and also served as a judge for the Streamy Awards for the last three years. Seth attended Utah Valley University.

Sandra Manning
Director of Strategic Operations

Director of Strategic Operations. Sandra is a serial entrepreneur and women’s health empowerment maven, who is incredibly in touch with our target demographic. Sandra has extensive experience in the nonprofit world, with roles ranging from administrator to management. Sandra holds a Bachelor of Arts in Organizational Communication, from the University of Utah. An avid outdoors woman, she can often be found at the top of a mountain.

Rachael Alger
Director of Customer Acquisition

Rachael loves helping clients through the on-boarding process and passionately believes it’s critical to improve and streamline the customer experience to maximize sales. She loves working with others to continually target and strategize about process improvement. Rachael brings over 15+ years of diverse experience in sales, health and media which dovetail nicely in her current position. Rachael holds a Bachelor of Science in Communications from the University of Texas.

Vaishnavi Narayan
Lead Machine Learning Engineer, Director of Engineering

Head of Data Science, Machine Learning, and Artificial Intelligence. Vaishnavi holds a Master’s of Science, Computer Science from Brigham Young University in Provo, Utah. Vaish’s accomplishments include designing a machine learning algorithm which could accurately predict critical mental health insights based on users social media posts. Her work since joining Frelii marries the human genome with artificial intelligence and has proven instrumental in both predictive health and predictive medicine. Vaish hails from Bangalore, India.

Christopher Dean
Vice President of Technology

Chris is seasoned coder who has pioneered new ways of processing health information. Chris was a founder and creator of the technology that became Navi Artificial Intelligence (AI). Mr. Dean in combination with his Lead AI developer Vaishnavi Narayan have created a new type of convolutional neural network and deep learning algorithm that works in unison to both understand humans and improve their quality of life. Chris has over 5 years of Coding DNA and AI related programs.

Board of Directors

Jim Spallino
Chairman of the Board

Jim has over 40 years of business experience working with fast growth companies. Jim has experience as a business founder, mentor, advisor and board member. Jim holds a degree from St John’s seminary college. He was the founder and CEO of Great White Dental, a top 50 US dental materials company. Jim specializes in taking companies from startup to profitability on a global scale. Golf and snow skiing are passions along with spending time with his grandkids.

Ian Jenkins
President and CEO

Ian Jenkins read his first book on DNA when he was 6 years old and was hooked for life. He has served as the Chief Executive Officer of Frélii, Inc. (formerly known as Vican Resources, Inc.) since April 5, 2017. He has several years of experience in finance, marketing and stock analysis; however, he never strayed far from his passion in genetics, particularly in epigenetics and expression, working in labs such as Midwestern Medical University, Davidson Genetics, Nutri-Biome Research and at the helm of companies driving this segment. Prior to Frélii, Jenkins has been the Managing Partner of Unprescribed, LLC since 2016. He served as a board advisor and Director of Marketing from 2012 to 2016 at Systemic Formulas Inc., and an Industry Consultant from 2011 to 2012 in Salt Lake City, Utah. Jenkins was a Turnaround Consultant with Coleridge Group – Phoenix, Arizona, from 2010 to 2011 and Chief Executive Officer of CodeTec – Phoenix, Arizona, from 2009 to 2010. Jenkins received a Bachelor of Science in Exercise Physiology in 2007 from Utah State University and an MBA, International Business / Entrepreneurship in 2011 from the Thunderbird School of Global Management – Glendale, AZ.

Tarek Mango
Board Member

Tarek is a leader in international business development as well as a trade expert. He currently serves as partner at Manthom Investments, LLC and is the CEO of Mango Enterprises. As such, Tarek has served as Director of International Business Development, where he spearheads export financing options, international consulting services, distribution channels, and distributor and client management. Tarek holds an MBA from Thunderbird School of Global Management, a BA in International Business from Westminster College, and a BA in Middle East Politics from the University of Utah.

Dr. Hans Jenkins
Cheif Medical Director

Jenkins was appointed to our Board of Directors in March 2018. Dr. Jenkins is highly experienced in developing lifestyle and nutrition plans for patients seeking to optimize their long-term health through preventive care. His practice prioritizes preventive health education, medical screenings, and lifestyle modifications to obtain optimal health. Dr. Jenkins graduated from Weber State University, then earned his Doctor of Osteopathy (D.O.) degree from Arizona College of Osteopathic Medicine. Following medical school, Dr. Jenkins completed a family medicine internship at John C. Lincoln Hospital in Phoenix, Arizona. An honored veteran of the United States Air Force, Dr. Jenkins served more than four years as a flight surgeon during Operation Iraqi Freedom with two deployments to combat zones. Dr. Jenkins completed his family medicine residency program at St. Joseph’s Hospital in 2011. Dr. Jenkins is the Medical Director and a primary care physician at Orn Total Health in Farmington, Utah.

Leslie Norris
Board Member

Leslie is a business strategist and currently the Founder and CEO of Springboard5 Marketing, a global strategic PR & Marketing firm that focuses on life science, biotech and technology companies. She is also Founder and CEO of ARCexperts, a global audit, risk and regulatory compliance firm that serves life science and biotech companies through all of their regulatory compliance and risk mitigation requirements. In addition, she serves as an independent consultant and advisor to companies to provide insight for business planning, executive leadership training and mentoring, operational efficiency, strategic planning, global emergence, brand development and channel development. Leslie has been an angel investor for 25 years and has worked with investment groups like Park City Angels and BioPacific.

Jayson Uffens
Chief Technology Officer

Jason is the Founder and CEO of a successful SAAS platform that helps connect financial institutions to meaningful engagement opportunities with customers through digital channels. Prior to this, he was the Vice President of GrubHub where he directed the creation of effective technology architecture which helped leapfrog their brand forward. He is an industry thought leader and companies from around the world seek his advice with their technology challenges.

Science Advisory Committee

Dr. Shane Morris

Dr. Shayne Morris is a molecular biologist and herbalomic expert. Dr. Morris’ specialty and research is in the body’s epigenetic response to herbal nutrition. Thus Dr. Morris’ cutting edge research is recognized as exactly what is needed for nutritional solutions in the 21st Century. In 2010, Dr. Morris helped Systemic Formulas usher in a new era of clinical and nutritional support of the body’s cellular healing processes, establishing Systemic Formulas as the world leader in cellular healing. Dr. Morris’ research is chronicled in a series of Research Reports available to health professionals.

Dr. Susan Morelli

Dr. Susan Morelli is a Neonatologist in Provo, Utah. Her specialty is in Human Genetics. Dr Morelli received her BA from Harvard, her medical degree from University of Connecticut School of Medicine and has been in practice for more than 20 years. She is a member of the American Academy of Pediatrics, American Board of Pediatrics, and the American Society of Human Genetics, American Board of Medical Genetics and Genomics . She is Board Certified as AM BD MEDICAL GENETICS CLINICAL GENETICS (MD/DO). Dr Morelli is a published lead author in several medical studies.

Dr. Anthony R. Torres

Dr. Anthony R. Torres is an independent researcher studying immune genes in autism and helping companies solve their biochemical problems in industry. Dr Torres holds several patents for novel inventions in the genetics field. Dr Torres attended University of Utah Medical School and Yale for his Residency. He is a senior scientist at the Center for Persons with Disabilities. Dr Torres has extensive publications in genetic research.

Firas Harb

Firas Harb holds a BS in Chemistry from Brigham Young University and a MS in Science and Technology from the University of Utah. Currently he is the Director of Inorganic Analysis at Genesys/Dyad Labs. Prior to joining Genysis Labs, Firas was the Metals Lab Director at Nutraceutical International Corp. for more than 12 years where he gained an extensive amount of experience in the analysis of dietary supplements, and specifically on the use of Inductive Coupled Plasma Mass Spectrometry (ICP/MS).